Select Biosciences Fourth Annual Liquid Biopsies and Minimally-Invasive Diagnostics 2017 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.

Slide Deck Downloads: Liquid Biopsy Slide Deck Exosomes Market Dynamics

This Liquid Biopsies Conference focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring.

This conference is held concurrently with the NGS, RNA-Seq, Single Cell Analysis & Single Molecule Analysis: Research to Diagnostics 2017 Conference enabling delegates full access to the presentations, co-located exhibit hall and extensive networking opportunities.